The reality of using primaquine
BACKGROUND: Primaquine is currently the only medication used for radical cure of Plasmodium vivax infection. Unfortunately, its use is not without risk. Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency have an increased susceptibility to haemolysis when given primaquine. This p...
Saved in:
Main Authors: | Burgoine, Kathy L., Bancone, Germana, Nosten, François |
---|---|
Format: | Article |
Language: | English |
Published: |
2016
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/720 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Language: | English |
Similar Items
-
Validation of a chloroquine-induced cell death mechanism for clinical use against malaria.
by: Ch’ng, J-H, et al.
Published: (2015) -
Chloroquine is grossly under dosed in young children with malaria: implications for drug resistance.
by: Ursing, Johan, et al.
Published: (2014) -
The reality of using primaquine
by: Kathy L. Burgoine, et al.
Published: (2018) -
Assessment of utilization of chloroquine and other antimalarial drugs in mataria endemic communities in Thailand
by: Wijitr Fungladda, et al.
Published: (2015) -
The threat of antimalarial drug resistance
by: Borimas Hanboonkunupakarn, et al.
Published: (2017)